Guilherme Henrique Campos Furtado

Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa

Guilherme Henrique Campos Furtado, Pedro Alves d’Azevedo, Anderson Fernandes Santos et al. · International Journal of Antimicrobial Agents · 2007 · 100 citations

Antimicrobial Susceptibility, Intravenous Polymyxin B, Antibiotics +10

Historical trends in the epidemiology of candidaemia: analysis of an 11-year period in a tertiary care hospital in Brazil

Marcos Paulo Wille, Thaís Guimarães, Guilherme Henrique Campos Furtado et al. · Memórias do Instituto Oswaldo Cruz · 2013 · 65 citations · Full text

Diagnostic Mycology, Clinical Mycology, Antimicrobial Chemotherapy +19

Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: An analysis of two case-control studies

Guilherme Henrique Campos Furtado, Rodrigo E. Mendes, Antônio Carlos Campos Pignatari et al. · American Journal of Infection Control · 2006 · 62 citations · Full text

Health Sciences, Antibiotics, Healthcare-associated Infection +10

The changing epidemiology of Acinetobacter spp. producing OXA carbapenemases causing bloodstream infections in Brazil: a BrasNet report

Ana Tereza Ribeiro de Vasconcelos, Afonso Luís Barth, Alexandre Prehn Zavascki et al. · Diagnostic Microbiology and Infectious Disease · 2015 · 57 citations

Acinetobacter Spp, Brasnet Report, Bloodstream Infections +5

<i>In Vivo</i> Efficacy of a Human-Simulated Regimen of Ceftaroline Combined with NXL104 against Extended-Spectrum-β-Lactamase (ESBL)-Producing and Non-ESBL-Producing Enterobacteriaceae

Dora E. Wiskirchen, Jared L. Crandon, Guilherme Henrique Campos Furtado et al. · Antimicrobial Agents and Chemotherapy · 2011 · 53 citations

Non-esbl-producing Enterobacteriaceae, Antimicrobial Chemotherapy, Antibiotic Resistance +21